Sangamo Therapeutics Inc. buy Barclays PLC
Start price
14.05.25
/
50%
€0.41
Target price
14.05.26
€4.47
Performance (%)
-62.54%
End price
15.05.26
-
Summary
This prediction is currently being closed. Massive losses of -62.54% have been the result for the BUY prediction by Barclays_PLC. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sangamo Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 1.014% | 2.699% | 4.363% |
| iShares Nasdaq 100 | -6.470% | -8.771% | 18.004% |
| iShares Nikkei 225® | -6.517% | -12.580% | 40.915% |
| iShares S&P 500 | -2.721% | -1.752% | 16.966% |
Comments by Barclays_PLC for this prediction
In the thread Sangamo Bioscienes diskutieren
Sangamo Therapeutics, Inc. (NASDAQ: SGMO) had its price target lowered by analysts at Barclays PLC from $9.00 to $5.00. They now have an "overweight" rating on the stock.
Ratings data for SGMO provided by MarketBeat
In the thread Trading Sangamo Bioscienes
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Barclays_PLC for Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.12
14.11.24
14.11.24
€8.52
14.11.25
14.11.25
-81.54%
15.11.25
15.11.25
